Related Experiment Video
Updated: Mar 16, 2026
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Shp2 suppresses the adipogenic differentiation of preadipocyte 3T3-L1 cells at an early stage
1School of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University , Xiamen, Fujian, China.
Abstract:
Tyrosine phosphatase protein Shp2 is a potential therapeutic target for obesity. However, the mechanism of Shp2 during adipogenesis is not fully understood. The present study investigated the role of Shp2 in the terminal differentiation of preadipocytes. The results showed that Shp2 suppressed adipocyte differentiation in 3T3-L1 cells; overexpression of Shp2 reduced lipid droplet production in 3T3-L1 cells, whereas Shp2 knockdown increased lipid droplet production in 3T3-L1 cells. Furthermore, inhibition of Shp2 activity also enhanced adipocyte differentiation. Interestingly, Shp2 expression was specifically decreased early during differentiation in response to stimulation with the dexamethasone-methylisobutylxanthine-insulin (DMI) hormone cocktail. During the first 2 days of differentiation, Shp2 overexpression impaired the DMI-induced phosphorylation of signal transducer and activator of transcription 3 (STAT3) in 3T3-L1 cells and blocked the peak expression of CCAAT/enhancer-binding proteins β and δ during preadipocyte differentiation. In conclusion, Shp2 downregulated the early stages of hormone-induced differentiation of 3T3-L1 cells and inhibited the expression of the first wave of transcription factors by suppressing the DMI-induced STAT3 signaling pathway. These discoveries point to a novel role of Shp2 during adipogenesis and support the hypothesis that Shp2 could be a therapeutic target for the control of obesity.
Insights
Tyrosine phosphatase Shp2 suppresses adipocyte differentiation by inhibiting STAT3 signaling. Targeting Shp2 may offer a new strategy for obesity treatment by promoting fat cell development.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Diseases
Background:
- Shp2 (tyrosine phosphatase) is implicated in metabolic regulation.
- Its precise role in adipogenesis (fat cell formation) remains unclear.
- Shp2 is a potential therapeutic target for obesity.
Purpose of the Study:
- To investigate the role of Shp2 in the terminal differentiation of preadipocytes.
- To elucidate the molecular mechanisms by which Shp2 influences adipogenesis.
Main Methods:
- Utilized 3T3-L1 cells, a standard model for adipogenesis research.
- Manipulated Shp2 expression (overexpression and knockdown) and activity.
- Analyzed lipid droplet accumulation, STAT3 phosphorylation, and transcription factor expression.
Main Results:
- Shp2 overexpression inhibited, while Shp2 knockdown enhanced, adipocyte differentiation and lipid accumulation.
- Shp2 activity inhibition also promoted differentiation.
- Shp2 expression decreased early during differentiation.
- Shp2 overexpression impaired DMI-induced STAT3 phosphorylation and blocked early transcription factor expression.
Conclusions:
- Shp2 negatively regulates early adipogenesis by suppressing DMI-induced STAT3 signaling.
- This suppression inhibits key transcription factors necessary for adipocyte differentiation.
- Shp2 represents a novel therapeutic target for obesity management through modulation of adipogenesis.
More Related Videos
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
09:52Investigation of Beige Fat Biology and Metabolism Using the CRISPR SunTag-p65-HSF1 Activation System
Published on: January 6, 2023